ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PTGX Protagonist Therapeutics Inc

26.09
0.55 (2.15%)
May 03 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 8.62M25.72M859k00000
Operating Income -37.02M-21.11M-41.44M-32.3M-36.52M-36.02M-42.35M-38.33M
Pre Tax Income -36.91M-20.93M-41.04M-31.23M-34.19M-33.73M-38.46M-34.11M
Net Income -36.91M-20.93M-41.04M-31.23M-34.19M-33.73M-38.46M-34.11M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -37.03M-21.1M-41.51M-32.39M-36.45M-36.22M-42.37M-38.36M
EBITDA -36.78M-20.86M-41.18M-32.03M-36.26M-35.77M-42.12M-38.08M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 020.06M30.93M231k28.63M27.36M26.58M60M
Operating Income -32.67M-37.9M-42.27M-80.52M-64.52M-125.85M-131.37M-93.65M
Pre Tax Income -37.18M-36.96M-39.72M-77.88M-64.85M-125.55M-127.39M-78.96M
Net Income -37.74M-36.96M-38.92M-77.19M-66.15M-125.55M-127.39M-78.96M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -2.257-1.753-1.679-2.836-1.512-2.625-2.582-1.369
EBIT -32.7M-37.9M-42.27M-80.52M-65.15M-125.99M-131.45M-93.85M
EBITDA -32.35M-37.49M-41.74M-79.82M-63.73M-125.03M-130.34M-92.68M

Your Recent History

Delayed Upgrade Clock